Resilience Stock
Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines and enhancing the biopharmaceutical supply chain. Founded in 2020, Resilience aims to build a sustainable network of high-tech, end-to-end manufacturing solutions that ensure the rapid, safe, and scalable production of medicines.
Sign up for SecondMarket™ to view the market and buy or sell Resilience Stock
Buy + SellResilience Funding
Sign up to gain insights into Resilience funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Feb 10, 2022 | Series D | 639.31M | ||
| Jul 12, 2021 | Series C | 600.00M | ||
| Nov 20, 2020 | Series B | 3.00M | ||
| Oct 23, 2020 | Series B | 725.00M | ||
| Aug 25, 2020 | Series A | 9.00M | ||
| Jul 31, 2020 | Series A | 44.88M |
See Resilience Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Resilience Stock Valuation + Share Prices
View real-time Tape D™ data on Resilience stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Resilience Management Team
Director
Mitchell Daniels, Jr.
Director
Mitchell Daniels, Jr.
Director
Scott Gottlieb
President, Chief Financial Officer, Chief Operating Officer
Sandesh Mahatme
CEO, Director
Rahul Singhvi
Director
Chris Darby
Director
Denice Torres
Director
Susan Desmond-Hellmann
Co-Founder
Celine Lazorthes
Director
Joseph Kerrey
Chief Scientific Officer
Rich Stoner
Director
Kaye Foster
Co-Founder
Jonathan Benhamou
Director
George Barrett
Director
Frances Arnold
Director
Drew Oetting
Director
Robert Nelsen
Resilience Major Investors
Exor Seeds
8VC
ARCH Venture Partners
Seaya Ventures
Cathay Innovation
New Enterprise Associates Inc (NEA)
Picus Capital GmbH
